Details

Autor(en) / Beteiligte

• Savla, Ronak
• Browne, Jeff
• Plassat, Vincent
• Wasan, Kishor M.
• Wasan, Ellen K.

Titel

Review and analysis of FDA approved drugs using lipid-based formulations

Ist Teil von

• Drug development and industrial pharmacy, 2017-11, Vol.43 (11), p.1743-1758

Ort / Verlag

England: Taylor & Francis

Erscheinungsjahr

2017

Quelle

EBSCOhost Business Source Ultimate

Beschreibungen/Notizen

• Lipid-based drug delivery systems (LBDDS) are one of the most studied bioavailability enhancement technologies and are utilized in a number of U.S. Food and Drug Administration (FDA) approved drugs. While researchers have used several general rules of thumb to predict which compounds are likely to benefit from LBDDS, formulation of lipid systems is primarily an empiric endeavor. One of the challenges is that these rules of thumb focus in different areas and are used independently of each other. The Developability Classification System attempts to link physicochemical characteristics with possible formulation strategies. Although it provides a starting point, the formulator still has to empirically develop the formulation. This article provides a review and quantitative analysis of the molecular properties of these approved drugs formulated as lipid systems and starts to build an approach that provides more directed guidance on which type of lipid system is likely to be the best for a particular drug molecule.